Viewing Study NCT03298061

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:49 PM
Ignite Modification Date: 2026-02-21 @ 12:04 PM
Study NCT ID: NCT03298061
Status: COMPLETED
Last Update Posted: 2024-03-12
First Post: 2017-09-27
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Churg-Strauss Syndrome View
None Eosinophilic Granulomatosis With Polyangiitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Eosinophilic Granulomatosis View
None MEA115921 View
None Polyangiitis View
None Long-term access program View
None mepolizumab View